SABS - SAB Biotherapeutics gets new finance chief
2023-10-24 08:00:12 ET
More on SAB Biotherapeutics
- SAB Biotherapeutics GAAP EPS of -$0.14
- Seeking Alpha’s Quant Rating on SAB Biotherapeutics
- Historical earnings data for SAB Biotherapeutics
For further details see:
SAB Biotherapeutics gets new finance chief